Quantiferon – Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
Condition(s):Cytomegalovirus InfectionLast Updated:April 23, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Cytomegalovirus InfectionLast Updated:April 23, 2012Completed
Condition(s):TransplantLast Updated:April 16, 2008Completed
Condition(s):Kidney Transplant InfectionLast Updated:February 1, 2023Not yet recruiting
Condition(s):Hematopoietic Stem Cell Transplantation; Cytomegalovirus Infections; Antivirals; Antiviral Drug ResistanceLast Updated:December 31, 2020Recruiting
Condition(s):Cytomegalovirus InfectionLast Updated:November 1, 2022Completed
Condition(s):Cytomegalovirus InfectionsLast Updated:June 10, 2010Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:June 11, 2014No longer available
Condition(s):Cytomegalovirus InfectionLast Updated:January 25, 2018Completed
Condition(s):Non-small Cell Lung Cancer Stage ILast Updated:August 13, 2019Withdrawn
Condition(s):Infection in Solid Organ Transplant RecipientsLast Updated:March 23, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.